304 studies found for:    biogen | biogen
Show Display Options
RSS Create an RSS feed from your search for:
biogen | biogen
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Patients
Condition: Rheumatoid Arthritis
Intervention: Biological: Baminercept alfa (BG9924)
2 Recruiting A Study Evaluating the Effectiveness of Tecfidera™ (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes
Conditions: Relapsing-Remitting Multiple Sclerosis;   Multiple Sclerosis
Intervention: Drug: dimethyl fumarate (DMF)
3 Completed Open-Label Safety Extension Study of Avonex
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1a (Avonex)
4 Terminated BG9924 in Combination With Methotrexate Extension of Study 104RA203
Condition: Rheumatoid Arthritis
Intervention: Drug: BG9924
5 Recruiting Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Condition: Multiple Sclerosis
Interventions: Drug: BIIB033;   Other: Placebo;   Drug: Interferon Beta-1a
6 Not yet recruiting Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate (DMF)-Treated Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: BG00012 (Dimethyl Fumarate);   Drug: Acetylsalicylic acid;   Drug: ASA-Placebo
7 Not yet recruiting A Phase 3b Study of BG00012's Effect on Vaccination Response in Subjects With Relapsed Forms of Multiple Sclerosis
Condition: Relapsing Forms of Multiple Sclerosis
Interventions: Drug: BG00012 (Dimethyl Fumarate);   Biological: Td (tetanus diphtheria toxoids);   Biological: Pneumococcal Vaccine;   Biological: KLH (Keyhole limpet hemocyanin)
8 Recruiting BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Subjects With Painful Lumbar Radiculopathy
Conditions: Painful Lumbar Radiculopathy;   Sciatica;   Radiculopathy
Interventions: Drug: BG00010;   Drug: Placebo
9 Recruiting Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
Condition: Healthy
Interventions: Drug: BIIB061;   Drug: Placebo;   Drug: 14C-BIIB061
10 Completed Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Patients
Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo;   Biological: baminercept alfa;   Biological: Baminercept alfa
11 Completed ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
Condition: Multiple Sclerosis
Intervention:
12 Recruiting 215ON201 BIIB033 In Acute Optic Neuritis (AON)
Condition: Acute Optic Neuritis
Intervention: Biological: BIIB033
13 Recruiting Anti-Tweak in Lupus Nephritis Patients
Condition: Lupus Nephritis
Interventions: Biological: BIIB023;   Biological: Placebo
14 Completed
Has Results
Natalizumab High Titer Immunogenicity and Safety
Condition: Multiple Sclerosis
Intervention: Drug: natalizumab
15 Completed A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)
Condition: Relapsing Forms of Multiple Sclerosis
Interventions: Procedure: Plasma exchange;   Drug: natalizumab treatment
16 Recruiting BIIB017 Related Flu-Like Symptoms in Relapsing Multiple Sclerosis Patients
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Biological: Peginterferon beta-1a;   Drug: naproxen
17 Recruiting A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Subjects With Multiple Sclerosis
Conditions: Multiple Sclerosis, Remittent Progressive;   Multiple Sclerosis, Primary Progressive;   Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: fampridine (BIIB041)
18 Recruiting Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010
Conditions: Painful Lumbar Radiculopathy;   Healthy
Interventions: Biological: BG00010;   Drug: Placebo
19 Recruiting An Efficacy and Safety Study of BG00012 in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: BG00012
20 Completed Open-Label Natalizumab Safety Extension Study
Condition: Multiple Sclerosis
Intervention: Drug: Natalizumab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years